Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis

European Journal of Clinical Investigation

Volumn 44, Issue 2, 2014, Pages 176-183

  Stokes, Caroline S ^a   Krawczyk, Marcin ^a   Reichel, Christoph ^b   Lammert, Frank ^a   Grünhage, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Clinic Hartwald   (Germany)

Author keywords

25 Hydroxyvitamin D; Cholecalciferol; Chronic liver disease; Survival analysis

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CHILD PUGH SCORE; CHRONIC LIVER DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; SURVIVOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; MIDDLE AGED; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84892483155     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12205     Document Type: Article

References (39)

1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608.
2. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006;367:52-6.
3. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int 2012;32:1407-14.
4. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-31.
5. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805.
6. Curto TM, Lagier RJ, Lok AS, Everhart JE, Rowland CM, Sninsky JJ. Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7). Pharmacogenet Genomics 2011;21:851-60.
7. Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-52.
8. Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012;30:284-9.
9. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012;95:91-100.
10. Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M et al. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 2012;32:845-51.
11. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
12. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624-8.
13. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007;5:513-20.
14. Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996;11:417-21.
15. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158-67.
16. Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011;53:1118-26.
17. Grünhage F, Hochrath K, Krawczyk M, Höblinger A, Obermayer-Pietsch B, Geisel J et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-91.
18. Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E et al. Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol 2010;16:3016-24.
19. Pourgholami MH, Akhter J, Lu Y, Morris DL. In vitro and in vivo inhibition of liver cancer cells by 1, 25-dihydroxyvitamin D3. Cancer Lett 2000;151:97-102.
20. Kitson MT, Dore GJ, George J, Button P, McCaughan GW, Crawford DH et al. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol 2013;58:467-72.
21. Ladero JM, Torrejon MJ, Sanchez-Pobre P, Suarez A, Cuenca F, de la Orden V et al. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C. Ann Hepatol 2013;12:199-204.
22. Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U et al. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death. Clin Gastroenterol Hepatol 2008;6:1255-62.
23. Reichel C, Sudhop T, Braun B, Kreuzer KA, Hahn C, Look MP et al. Elevated soluble tumour necrosis factor receptor serum concentrations and short-term mortality in liver cirrhosis without acute infections. Digestion 2000;62:44-51.
24. Thomas GN, o HB, Bosch JA, Pilz S, Loerbroks A, Kleber ME et al. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the ludwigshafen risk and cardiovascular health (LURIC) Study. Diabetes Care 2012;35:1158-64.
25. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009;76:977-83.
26. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 2011;50:z305-12.
27. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al. Vitamin D status and cause-specific mortality: a general population study. PLoS One 2012;7:e52423.
28. Trepo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C et al. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. J Hepatol 2013;59:334-50.
29. Grant WB. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol 2009;1:37-42.
30. Flynn L, Zimmerman LH, McNorton K, Dolman M, Tyburski J, Baylor A et al. Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg 2012;203:379-82.
31. Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest 1998;114:1122-8.
32. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
33. White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 2012;13:21-9.
34. Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 2010;107:22593-8.
35. Dixon BM, Barker T, McKinnon T, Cuomo J, Frei B, Borregaard N et al. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes 2012;5:575.
36. Lee WJ, Cha HW, Sohn MY, Lee SJ, Kim do W. Vitamin D increases expression of cathelicidin in cultured sebocytes. Arch Dermatol Res 2012;304:627-32.
37. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006;36:361-70.
38. Plessis JD, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol 2013;58:1125-32.
39. Zhang C, Zhao L, Ma L, Lv C, Ding Y, Xia T et al. Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis. Dig Dis Sci 2012;57:182-8.